Who Paid My Doc
Robert Redfield
Transplant Surgery Orange, CA Medical Doctor
NPI 1326195082 CMS profile 856287
101 The City Dr S, Orange, CA 92868
General payments
$65,439
Research payments
$739
Ownership & investment interest
$0
Research they led as principal investigator
$1,037,534
Through program year 2025, Robert Redfield of Orange, CA is reported in the CMS Open Payments database as having received $65,439 across 92 general payments and $739 in research payments paid to them. Separately, studies naming them as principal investigator received $1,037,534 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Transplant Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,811 | 4 | |
| 2024 | General | $1,734 | 10 | |
| 2023 | General | $3,596 | 2 | |
| 2022 | General | $5,916 | 15 | |
| 2022 | Research | $739 | 2 | |
| 2021 | General | $28,777 | 31 | |
| 2020 | General | $21,904 | 18 | |
| 2019 | General | $1,701 | 12 |
Beside peers
- Robert Redfield
- Transplant Surgery median
- Middle half of Transplant Surgery
- National median
In program year 2025, general payments to Robert Redfield were reported at $1,811. Among 555 Transplant Surgery profiles paid that year, the median was $421 and the middle half received between $116 and $2,169.
Show as a table
| Year | Robert Redfield | Transplant Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,701 | $203 | $77–$1,249 | $163 |
| 2020 | $21,904 | $149 | $52–$1,366 | $114 |
| 2021 | $28,777 | $168 | $73–$2,008 | $132 |
| 2022 | $5,916 | $213 | $94–$1,464 | $149 |
| 2023 | $3,596 | $262 | $93–$1,458 | $160 |
| 2024 | $1,734 | $354 | $126–$2,252 | $164 |
| 2025 | $1,811 | $421 | $116–$2,169 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 21 billing codesPaid by Medicare
$112,037
Medicare patients
64
Services billed
609
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Chronic kidney disease | 75% | |
| Diabetes | 64% | |
| Heart failure | 38% | |
| Ischemic heart disease | 38% | |
| Atrial fibrillation | 19% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
1 product · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| THYMOGLOBULIN |
|
$269 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
94 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Transplant Surgery in California
Elizabeth Squiers
Transplant Surgery · Half Moon Bay, CA
Myron Tong
Transplant Surgery · Pasadena, CA
Yuri Genyk
Transplant Surgery · Los Angeles, CA
Angeles Baquerizo
Transplant Surgery · La Jolla, CA
Navpreet Kaur
Transplant Surgery · Los Angeles, CA
Gerald Lipshutz
Transplant Surgery · Los Angeles, CA
Related records
Transplant Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Transplant Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.